phenylpropanolamine (PPA)

From Aaushi
Jump to navigation Jump to search

Introduction

FDA has removed phenylpropanolamine from the market 12/2000. Isolated cases of hemorrhagic stroke in young women have been associated with phenylpropanolamine.[4]

Dosage

25 mg PO every 4 hours

Tabs: 25 & 50 mg.

Sustained-release: 75 mg PO every 12 hours. Tabs: 75 mg.

Pharmacokinetics

elimination via liver

Adverse effects

Drug interactions

Mechanism of action

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
  3. Kaiser Permanente, Northern California Drug Alert, 11, 2000
  4. Jump up to: 4.0 4.1 4.2 Chan JJ, Chan M, Wright JM Effect of adrenergic agonist oral decongestants on blood pressure. Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD007895. PMID: https://www.ncbi.nlm.nih.gov/pubmed/40145549 PMCID: PMC11948476 (available on 2026-03-27)
  5. Phenylpropanolamine Information Page http://wwwfda.gov/cder/drug/infopage/ppa/default.htm

Database